Showing results (31-40 of 394) with videos related to
Sort By:
Pageof 40
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysisUrania Dafni, Zoi Tsourti, Katerina Vervita, et al.NPJ Precision Oncology|April 16, 2024
BRAFV600E-mutant metastatic NSCLC: disease overview and treatment landscapeDavid Planchard, Rachel E Sanborn, Marcelo V Negrao, et al.Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|July 24, 2018
Acceptance of the Advanced Practice Nurse in Lung Cancer Role by Healthcare Professionals and Patients: A Qualitative ExplorationAndrea Serena, Andrew A Dwyer, Solange Peters, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Immune Checkpoint Inhibitors in the Management of Lung CancerStefan Zimmermann, Solange Peters, Taofeek Owinokoko, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2019
Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung CancerPablo Martinez, Solange Peters, Timothy Stammers, et al.Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L)Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, et al.Cancer Discovery|April 3, 2021
The Promising Evolution of Targeted Therapeutic Strategies in CancerSolange Peters, Tony Mok, Antonio Passaro, et al.Nature Cancer|February 5, 2022
Overcoming therapy resistance in EGFR-mutant lung cancerAntonio Passaro, Pasi A Jänne, Tony Mok, et al.Pageof 40